482 related articles for article (PubMed ID: 12790881)
21. High levels of iron supplementation prevents neural tube defects in the Fpn1
Stokes BA; Sabatino JA; Zohn IE
Birth Defects Res; 2017 Jan; 109(2):81-91. PubMed ID: 28008752
[TBL] [Abstract][Full Text] [Related]
22. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation.
Yerby MS
Epilepsia; 2003; 44 Suppl 3():33-40. PubMed ID: 12790884
[TBL] [Abstract][Full Text] [Related]
23. Periconceptional folic acid use prevents both rare and common neural tube defects in China.
Zhou Y; Crider KS; Yeung LF; Rose CE; Li Z; Berry RJ; Li S; Moore CA
Birth Defects Res; 2022 Mar; 114(5-6):184-196. PubMed ID: 35098705
[TBL] [Abstract][Full Text] [Related]
24. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
[TBL] [Abstract][Full Text] [Related]
25. Birth prevalence of neural tube defects in eastern Africa: a systematic review and meta-analysis.
Ssentongo P; Heilbrunn ES; Ssentongo AE; Ssenyonga LVN; Lekoubou A
BMC Neurol; 2022 Jun; 22(1):202. PubMed ID: 35650541
[TBL] [Abstract][Full Text] [Related]
26. Periconceptional folic acid supplementation and sex difference in prevention of neural tube defects and their subtypes in China: results from a large prospective cohort study.
Liu J; Li Z; Ye R; Liu J; Ren A
Nutr J; 2018 Dec; 17(1):115. PubMed ID: 30541549
[TBL] [Abstract][Full Text] [Related]
27. Understanding the increased risk of neural tube defect-affected pregnancies among Mexico-born women in California: immigration and anthropometric factors.
Velie EM; Shaw GM; Malcoe LH; Schaffer DM; Samuels SJ; Todoroff K; Block G
Paediatr Perinat Epidemiol; 2006 May; 20(3):219-30. PubMed ID: 16629696
[TBL] [Abstract][Full Text] [Related]
28. The Aperta type of neural tube defect: The relevant experience in a local community with the diversity of the presentation.
Hakim WS; Aljanabi AS
J Med Life; 2023 Oct; 16(10):1499-1502. PubMed ID: 38313183
[TBL] [Abstract][Full Text] [Related]
29. East Ireland 1980-1994: epidemiology of neural tube defects.
McDonnell RJ; Johnson Z; Delaney V; Dack P
J Epidemiol Community Health; 1999 Dec; 53(12):782-8. PubMed ID: 10656087
[TBL] [Abstract][Full Text] [Related]
30. Neural tube defect diagnosis and outcomes at a tertiary South African hospital with intensive case ascertainment.
Krzesinski EI; Geerts L; Urban MF
S Afr Med J; 2019 Aug; 109(9):698-703. PubMed ID: 31635597
[TBL] [Abstract][Full Text] [Related]
31. Survival of infants with neural tube defects in the presence of folic acid fortification.
Bol KA; Collins JS; Kirby RS;
Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
[TBL] [Abstract][Full Text] [Related]
32. Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China.
Chen G; Song X; Ji Y; Zhang L; Pei L; Chen J; Liu J; Li C; Zheng X
Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):592-6. PubMed ID: 18634013
[TBL] [Abstract][Full Text] [Related]
33. Reducing inequities in preventable neural tube defects: the critical and underutilized role of neurosurgical advocacy for folate fortification.
Estevez-Ordonez D; Davis MC; Hopson B; ; Arynchyna A; Rocque BG; Fieggen G; Rosseau G; Oakley G; ; Blount JP
Neurosurg Focus; 2018 Oct; 45(4):E20. PubMed ID: 30269587
[TBL] [Abstract][Full Text] [Related]
34. [Risk of recurrence in major craniospinal malformations between 1976 and 2005].
Joó JG; Papp Z
Orv Hetil; 2007 Apr; 148(15):689-95. PubMed ID: 17416577
[TBL] [Abstract][Full Text] [Related]
35. Associated malformations in cases with neural tube defects.
Stoll C; Alembik Y; Dott B
Genet Couns; 2007; 18(2):209-15. PubMed ID: 17710873
[TBL] [Abstract][Full Text] [Related]
36. High burden of neural tube defects in Tigray, Northern Ethiopia: Hospital-based study.
Berihu BA; Welderufael AL; Berhe Y; Magana T; Mulugeta A; Asfaw S; Gebreselassie K
PLoS One; 2018; 13(11):e0206212. PubMed ID: 30427877
[TBL] [Abstract][Full Text] [Related]
37. Supplement use and other characteristics among pregnant women with a previous pregnancy affected by a neural tube defect - United States, 1997-2009.
Arth A; Tinker S; Moore C; Canfield M; Agopian A; Reefhuis J;
MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):6-9. PubMed ID: 25590679
[TBL] [Abstract][Full Text] [Related]
38. Folate status and health: challenges and opportunities.
Obeid R; Oexle K; Rißmann A; Pietrzik K; Koletzko B
J Perinat Med; 2016 Apr; 44(3):261-8. PubMed ID: 25825915
[TBL] [Abstract][Full Text] [Related]
39. An Audit of Neural Tube Defects in the Republic Of Ireland for 2012-2015.
McDonnell R; Delany V; O'Mahony MT; Lynch C; McKeating A; McKeating A; Turner MJ
Ir Med J; 2018 Mar; 111(3):712. PubMed ID: 30376230
[TBL] [Abstract][Full Text] [Related]
40. Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México.
Martínez de Villarreal L; Pérez JZ; Vázquez PA; Herrera RH; Campos Mdel R; López RA; Ramírez JL; Sánchez JM; Villarreal JJ; Garza MT; Limón A; López AG; Bárcenas M; García JR; Domínguez AS; Nuñez RH; Ayala JL; Martínez JG; González MT; Alvarez CG; Castro RN
Teratology; 2002 Nov; 66(5):249-56. PubMed ID: 12397633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
